Literature DB >> 28176637

Personalized Medicine Applied to Forensic Sciences: New Advances and Perspectives for a Tailored Forensic Approach.

Alessandro Santurro1, Anna Maria Vullo1, Marina Borro2, Giovanna Gentile2, Raffaele La Russa3, Maurizio Simmaco2, Paola Frati1, Vittorio Fineschi4.   

Abstract

Personalized medicine (PM), included in P5 medicine (Personalized, Predictive, Preventive, Participative and Precision medicine) is an innovative approach to the patient, emerging from the need to tailor and to fit the profile of each individual. PM promises to dramatically impact also on forensic sciences and justice system in ways we are only beginning to understand. The application of omics (genomic, transcriptomics, epigenetics/imprintomics, proteomic and metabolomics) is ever more fundamental in the so called "molecular autopsy". Emerging fields of interest in forensic pathology are represented by diagnosis and detection of predisposing conditions to fatal thromboembolic and hypertensive events, determination of genetic variants related to sudden death, such as congenital long QT syndromes, demonstration of lesions vitality, identification of biological matrices and species diagnosis of a forensic trace on crime scenes without destruction of the DNA. The aim of this paper is to describe the state-of-art in the application of personalized medicine in forensic sciences, to understand the possibilities of integration in routine investigation of these procedures with classical post-mortem studies and to underline the importance of these new updates in medical examiners' armamentarium in determining cause of death or contributing factors to death. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Personalized medicine; forensic sciences; genomics; metabolomics; molecular autopsy; pharmacogenomics; proteomics; sudden death; theragnostic; transcriptomics

Mesh:

Substances:

Year:  2017        PMID: 28176637     DOI: 10.2174/1389201018666170207141525

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  6 in total

1.  Folate-receptor-targeted laser-activable poly(lactide-co-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy.

Authors:  Fengqiu Liu; Yuli Chen; Yizhen Li; Yuan Guo; Yang Cao; Pan Li; Zhigang Wang; Yuping Gong; Haitao Ran
Journal:  Int J Nanomedicine       Date:  2018-09-06

2.  Cephalosporins' Cross-Reactivity and the High Degree of Required Knowledge. Case Report and Review of the Literature.

Authors:  Stefano D'Errico; Paola Frati; Martina Zanon; Eleonora Valentinuz; Federico Manetti; Matteo Scopetti; Alessandro Santurro; Vittorio Fineschi
Journal:  Antibiotics (Basel)       Date:  2020-04-25

3.  Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.

Authors:  Domas Naujokaitis; Virginija Asmoniene; Edmundas Kadusevicius
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

4.  Fatal food-induced anaphylaxis: Determination of tryptase and specific IgE on cadaveric blood samples. What else for a better methodological standard?

Authors:  Stefano D'Errico; Alessandro Santurro; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

Review 5.  Omics era in forensic medicine: towards a new age

Authors:  Ramazan Akçan; Burak Taştekin; Mahmut Şerif Yildirim; Halit Canberk Aydogan; Necdet Sağlam
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

6.  Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit?: A case report.

Authors:  Stefano D'Errico; Benedetta Baldari; Mauro Arcangeli; Alessandro Santurro; Paola Frati; Vittorio Fineschi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.